Direct and indirect effects of the covid-19 pandemic and response in South Asia

41

Supplementary Tables

Supplementary tables

Table 1:

Compartments and functional definitions of the model

Compartment	Functional definition
S	Susceptible individuals
E	Exposed and infected, not yet symptomatic but potentially infectious
I	Infected, symptomatic, and infectious
Q	Infectious, but (self-)isolated
H	Requiring hospitalization (would normally be hospitalised if capacity available)
R	Recovered, immune from further infection
F	Case fatality (death due to COVID-19, not other causes)

Table 2:

Model parameters for base case scenarios

Variable name	Description	No intervention	Hand hygiene	Face masks	Smart lockdowns	Comments
s.num	Initial number of susceptible (not yet infected) individuals in the simulated population.	Population size divided by the cumulative number of known active cases at the beginning of the calibration period				These values were chosen to scale the simulation size to q.num = 1.
e.num	Initial number of exposed (infected, asymptomatic, and potentially infectious) individuals in the simulated population.	1 at start of calibration. Simulation starts with the value obtained at the end of the calibration period.				Assumptions made for the model; discussed in the manuscript
i.num	Initial number of infected (symptomatic and infectious) individuals in the simulated population.	1 at start of calibration. Simulation starts with the value obtained at the end of the calibration period.				Assumptions made for the model; discussed in the manuscript
q.num	Initial number of infectious but quarantined.	1 at start of calibration. Simulation starts with the value obtained at the end of the calibration period.				The simulation size was scaled according to this choice.
h.num	Initial number of individuals requiring hospitalization.	0 at start of calibration. Simulation starts with the value obtained at the end of the calibration period.				Assumed zero at the beginning of calibration.
r.num	Initial number of recovered (and immune) individuals.	0 at start of calibration. Simulation starts with the value obtained at the end of the calibration period.				Assumed zero at the beginning of calibration.

42

Supplementary Tables

s.num

Population size divided by the cumulative number of

known active cases at the beginning of the calibration period

Initial number of

susceptible (not yet infected) individuals in the simulated population.

Initial number of exposed (infected, asymptomatic,

These values were chosen to

scale the simulation size to q.num = 1.

Assumptions made for the

1 at start of c

value obtain

1 at start of c value obtain

1 at start of c value obtain

alibration. Si

d at the end o

alibration. Si d at the end o

alibration. Si d at the end o

mulation sta

f the calibra

mulation sta f the calibra

mulation sta f the calibra

rts with the

tion period.

rts with the tion period.

rts with the tion period.

e.num

i.num

q.num h.num r.num

and potentially infectious)

individuals in the simulated population.

Initial number of infected (symptomatic and infectious) individuals in the simulated population.

Initial number of infectious but quarantined.

Initial number of individuals requiring hospitalization.

Initial number of recovered (and immune) individuals.

0 at start of calibration. Simulation starts with the

value obtained at the end of the calibration period.

0 at start of calibration. Simulation starts with the value obtained at the end of the calibration period.

model; discussed in the

manuscript

Assumptions made for the model; discussed in the manuscript

The simulation size was scaled according to this choice.

Assumed zero at the beginning of calibration.

Assumed zero at the beginning of calibration.